APA

Hatfield K. J., Olsnes A. M., Gjertsen B. T. & Bruserud Ø. (20050830). Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies. : Current cancer drug targets.

Chicago

Hatfield Kimberley J, Olsnes Astrid M, Gjertsen Bjorn Tore and Bruserud Øystein. 20050830. Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies. : Current cancer drug targets.

Harvard

Hatfield K. J., Olsnes A. M., Gjertsen B. T. and Bruserud Ø. (20050830). Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies. : Current cancer drug targets.

MLA

Hatfield Kimberley J, Olsnes Astrid M, Gjertsen Bjorn Tore and Bruserud Øystein. Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies. : Current cancer drug targets. 20050830.